Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
25.12
-0.64 (-2.48%)
Aug 14, 2026, 4:00 PM EDT - Market closed
Zymeworks Market Cap
Zymeworks has a market cap or net worth of $1.78 billion as of August 14, 2026. Its market cap has increased by 70.12% in one year.
Market Cap
1.78B
Enterprise Value
1.48B
1-Year Change
70.12%
Ranking
Category
Stock Price
$25.12
ChartMarket Cap Chart
Since April 28, 2017, Zymeworks's market cap has increased from $329.40M to $1.78B, an increase of 441.13%. That is a compound annual growth rate of 19.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 1.78B | -9.54% |
| Dec 31, 2025 | 1.97B | 95.40% |
| Dec 31, 2024 | 1.01B | 38.65% |
| Dec 29, 2023 | 727.30M | 46.87% |
| Dec 30, 2022 | 495.20M | -35.10% |
| Dec 31, 2021 | 763.00M | -64.77% |
| Dec 31, 2020 | 2.17B | 20.97% |
| Dec 31, 2019 | 1.79B | 281.53% |
| Dec 31, 2018 | 469.30M | 143.92% |
| Dec 29, 2017 | 192.40M | -41.59% |
| Apr 28, 2017 | 329.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 1.90B |
| Kardigan | 1.89B |
| Lakefront Biotherapeutics NV | 1.82B |
| Syndax Pharmaceuticals | 1.77B |
| Immunocore Holdings | 1.76B |
| Avalyn Pharma | 1.74B |
| Xencor | 1.74B |
| Braveheart Bio | 1.73B |